Zacks Research Raises Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research boosted their FY2026 EPS estimates for Henry Schein in a report issued on Monday, May 25th. Zacks Research analyst Team now expects that the company will earn $5.30 per share for the year, up from their prior forecast of $5.26. The consensus estimate for Henry Schein’s current full-year earnings is $5.31 per share. Zacks Research also issued estimates for Henry Schein’s FY2027 earnings at $5.81 EPS, Q1 2028 earnings at $1.64 EPS and FY2028 earnings at $6.29 EPS.

Other equities research analysts also recently issued reports about the stock. UBS Group reiterated a “neutral” rating and set a $85.00 price objective (down from $87.00) on shares of Henry Schein in a research note on Wednesday, May 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a report on Monday, May 4th. Robert W. Baird set a $97.00 target price on shares of Henry Schein in a report on Wednesday, May 6th. Citigroup initiated coverage on shares of Henry Schein in a report on Wednesday, April 15th. They issued a “buy” rating and a $100.00 target price for the company. Finally, Mizuho dropped their target price on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $86.83.

Henry Schein Trading Down 0.4%

Shares of Henry Schein stock opened at $73.90 on Wednesday. The company has a market capitalization of $8.42 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 1.86 and a beta of 0.82. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59. Henry Schein has a 12-month low of $61.94 and a 12-month high of $89.29. The firm’s 50-day moving average price is $74.29 and its two-hundred day moving average price is $75.73.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. The firm had revenue of $3.37 billion for the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS.

Insider Transactions at Henry Schein

In other news, Director Philip A. Laskawy sold 2,844 shares of the stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $80.36, for a total value of $228,543.84. Following the completion of the transaction, the director owned 21,961 shares of the company’s stock, valued at approximately $1,764,785.96. This represents a 11.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William K. Daniel bought 10,000 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was bought at an average cost of $69.19 per share, with a total value of $691,900.00. Following the acquisition, the director directly owned 20,000 shares of the company’s stock, valued at approximately $1,383,800. The trade was a 100.00% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have sold 105,911 shares of company stock valued at $8,574,982. 0.89% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. CYBER HORNET ETFs LLC bought a new position in Henry Schein in the 2nd quarter valued at approximately $25,000. MUFG Securities EMEA plc bought a new position in Henry Schein in the 2nd quarter valued at approximately $27,000. Flagship Harbor Advisors LLC bought a new position in Henry Schein in the 4th quarter valued at approximately $30,000. Federated Hermes Inc. bought a new position in Henry Schein in the 4th quarter valued at approximately $32,000. Finally, Los Angeles Capital Management LLC bought a new position in Henry Schein in the 4th quarter valued at approximately $37,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.